Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]

Zavzpret is the first fast-acting migraine nasal spray

Zavzpret is the first fast-acting migraine nasal spray

Zavzpret (active ingredient – vegepant) – the first and only nasal spray intended for migraine adults treatment, was recently approved by the FDA. Pfizer announced this on March 10, 2023. It is a calcitonin gene-related peptide (CGRP) receptor antagonist. The drug is intended for treatment of adult patients with migraine with or without aura. CGRP

Mounjaro™ (Tirzepatide) is a new and effective dual action drug for patients with type 2 diabetes and obesity

Mounjaro™ (Tirzepatide) is a new and effective dual action drug for patients with type 2 diabetes and obesity

Mounjaro™(Tirzepatide) by the pharmaceutical company Eli Lilly, which received FDA (Food and Drug Administration) approval for type 2 diabetes treatment in May 2022, has successfully passed the third phase of clinical trials as an effective means to reduce weight. The pharmaceutical company has already submitted a request to FDA for registration of Mounjaro™ as a